| 2006D-0347 | Guidance for Industry, Clinical Laboratories, and FDA Staff on In Vitro Diagnostic Multivariate Index Assays | |||||||||||||||||||||||
| FDA Comment Number : | EC19 | |||||||||||||||||||||||
| Submitter : | Mrs. Mary Steele Williams | Date & Time: | 02/22/2007 10:02:06 | |||||||||||||||||||||
| Organization : | Association for Molecular Pathology | |||||||||||||||||||||||
| Category : | Health Care Association | |||||||||||||||||||||||
| Issue Areas/Comments | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| Text of comments for the Feb. 8 Public Meeting are attached. I will send slides later in a separate posting. AMP intends to respond more fully before the March 5 deadline. Thanks very much.
Regards, Mary Steele Williams (301) 634-7921 mwilliams@asip.org | ||||||||||||||||||||||||
| 2006D-0347-EC19-Attach-1.PDF | ||||||||||||||||||||||||